US Patent 8012482 Humanized anti-TGF-beta antibodies
Patent 8012482 was granted and assigned to Genentech on September, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 7 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 4 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+292 characters)
Article
Patent abstract
Humanized anti-TGF-beta antibodies are provided, as well as methods for their preparation and use, including methods for treating TGF-beta disorders, for example, cancer. Also provided are articles of manufacture designed for various uses that contain the humanized antibodies.
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Camellia W. Adams0
Ellen Filvaroff0
Leonard G. Presta0
Max L. Tejada0
Napoleone Ferrara0
Weiguang Mao0
Edits on 19 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08012482 Humanized anti-TGF-beta antibodies US Patent 8012482 Humanized anti-TGF-beta antibodies
Infobox
Patent Number
08012482
Patent Number
8012482
Edits on 13 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08012482 Humanized anti-TGF-beta antibodies
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08012482
Date of patent
September 6, 2011
Patent application number
12423664
Date Filed
April 14, 2009
Patent primary examiner
Find more entities like US Patent 8012482 Humanized anti-TGF-beta antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
